Plenary Session 2: Liver Tuesday, October 21 8:30 am – 10:00 am MODERATORS: Kris V. Kowdley, MD, FACG Paul Y.…
Advancing GI’s Public Policy Priorities in Congress: A Recap of ACG’s Annual Advocacy Day
ACG leaders advance GI’s public policy priorities in Congress, including utilization management reform and colorectal cancer screening
IBS Awareness Month 2024
April is IBS Awareness Month. ACG is here for the busy clinician with resources on Irritable Bowel Syndrome: patient education materials, guidelines, lectures, podcasts, journal articles, and more.
March is Colorectal Cancer Awareness Month
Explore Resources & Inspiration from ACG Reezwana Chowdhury, MD, FACG; Chair, ACG Public Relations Committee March Colorectal Cancer Awareness Month…
ACG “Ride or Stride for 45” in March
Bike, run or walk 45 miles in March 2024 (or 45 minutes per day) to show your support and enthusiasm for preventing colorectal cancer screening starting at age 45.
Regional Variation of Care for Irritable Bowel Syndrome in the United States
P1719 Regional Variation of Care for Irritable Bowel Syndrome in the United States Author insight from Brian E. Lacy, MD,…
Colorectal Cancer Patients Have Higher Rates of Advanced Features in Their Diminutive Adenomas Compared to Patients Undergoing Average-Risk Screening
Plenary Session 2: Stomach/Colon Wednesday, October 22 8:30 am – 10:15 am Moderators: Joseph C. Anderson, MD Francisco C. Ramirez,…
Protein Shakes: An Unusual Cause of Gastric Phytobezoar in a Health Obsessed Person
P1296 Protein Shakes: An Unusual Cause of Gastric Phytobezoar in a Health Obsessed Person Author insight from Jagpal S. Klair,…
Normalization of Liver-Related Laboratory Parameters in HCV Genotype 1-Infected Patients With Cirrhosis After Treatment With ABT-450/R/Ombitasvir, Dasabuvir and Ribavirin
PRESIDENT’S PLENARY SESSION 1 Monday, October 20 8:00 am – 9:00 am (Terrace Ballroom) Moderators: Harry E. Sarles, Jr., MD,…
Outcomes of Fecal Microbiota Transplantation for Clostridium difficile Infection in Patients With Inflammatory Bowel Disease
P454 Outcomes of Fecal Microbiota Transplantation for Clostridium difficile Infection in Patients With Inflammatory Bowel Disease Author insight from Monika…
Risk Factors for Malignant Progression of Intraductal Papillary Mucinous Neoplasms (IPMN): An International Registry Cohort
Plenary Session 2: Pancreatic / Biliary Tuesday, October 21 2:15 pm – 3:45 pm Moderators: Linda S. Lee, MD Scott…
Cognitive Behavioral Self-Help for Irritable Bowel Syndrome
P1110 Cognitive Behavioral Self-Help for Irritable Bowel Syndrome Author insight from Melissa G. Hunt, PhD, University of Pennsylvania, Philadelphia, PA…
Acute Pancreatitis (AP) in Post-Bariatric Surgery (BRS) Status: Analysis of National Trends, Complications and Outcomes from 2007 to 2011 2014 ACG Obesity Award
Plenary Session 2: Pancreatic/Biliary Tuesday, October 21 2:15 pm – 3:45 pm Moderators: Linda S. Lee, MD Scott M. Tenner,…
Fecal Microbiota Transplant for Treatment of Refractory C. difficile Colitis: Long-Term Follow-Up of 58 Patients
P1639 Fecal Microbiota Transplant for Treatment of Refractory C. difficile Colitis: Long-Term Follow-Up of 58 Patients Author insight from Daniel…